Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-24 @ 6:40 PM
NCT ID:
NCT00973557
Eligibility Criteria:
Inclusion Criteria:
* Patients with colorectal cancer, lung cancer, breast cancer, and glioblastoma patients that have been treated with Bevacizumab for at least 1 month
* Adults (18 years of age or older)
Exclusion Criteria:
* Patients who are taking medications known to affect serum prolactin levels
* Patients who are pregnant
* Patients who have pituitary disease
* Minors (Under the age of 18)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00973557
Study Brief:
Protocol Section:
NCT00973557